Adrien Lupieri

520 total citations
16 papers, 278 citations indexed

About

Adrien Lupieri is a scholar working on Molecular Biology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Adrien Lupieri has authored 16 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Adrien Lupieri's work include Atherosclerosis and Cardiovascular Diseases (4 papers), Streptococcal Infections and Treatments (3 papers) and Extracellular vesicles in disease (2 papers). Adrien Lupieri is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (4 papers), Streptococcal Infections and Treatments (3 papers) and Extracellular vesicles in disease (2 papers). Adrien Lupieri collaborates with scholars based in United States, France and Russia. Adrien Lupieri's co-authors include Elena Aïkawa, Lívia Silva Araújo Passos, Muriel Laffargue, Natalia Smirnova, Masanori Aikawa, Nicole Malet, Stéphanie Gayral, Jean‐François Arnal, Françoise Lenfant and Alexia Vinel and has published in prestigious journals such as Circulation, Circulation Research and Journal of Cell Science.

In The Last Decade

Adrien Lupieri

15 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrien Lupieri United States 9 108 67 59 54 29 16 278
Anastasia A. Zharikova Russia 10 166 1.5× 25 0.4× 49 0.8× 62 1.1× 20 0.7× 51 319
Chiara Baggio Italy 10 85 0.8× 46 0.7× 34 0.6× 86 1.6× 29 1.0× 28 275
Hagit Baris Feldman Israel 11 131 1.2× 34 0.5× 71 1.2× 13 0.2× 31 1.1× 42 366
Kazuta Yasui Japan 13 120 1.1× 156 2.3× 98 1.7× 15 0.3× 33 1.1× 43 476
Frank Dastvan United States 9 223 2.1× 111 1.7× 34 0.6× 64 1.2× 43 1.5× 9 418
Taylor A. Johnson United States 8 170 1.6× 35 0.5× 13 0.2× 103 1.9× 19 0.7× 19 319
Wenman Wu China 12 155 1.4× 42 0.6× 89 1.5× 35 0.6× 26 0.9× 69 539
Qingfeng Yu China 14 203 1.9× 29 0.4× 35 0.6× 16 0.3× 13 0.4× 37 427
Wenying Zheng China 10 173 1.6× 23 0.3× 25 0.4× 25 0.5× 15 0.5× 15 298
Avshesh Mishra India 9 77 0.7× 33 0.5× 14 0.2× 85 1.6× 22 0.8× 15 228

Countries citing papers authored by Adrien Lupieri

Since Specialization
Citations

This map shows the geographic impact of Adrien Lupieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrien Lupieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrien Lupieri more than expected).

Fields of papers citing papers by Adrien Lupieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrien Lupieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrien Lupieri. The network helps show where Adrien Lupieri may publish in the future.

Co-authorship network of co-authors of Adrien Lupieri

This figure shows the co-authorship network connecting the top 25 collaborators of Adrien Lupieri. A scholar is included among the top collaborators of Adrien Lupieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrien Lupieri. Adrien Lupieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Felix, Nicole, Giuliano Generoso, Rhanderson Cardoso, et al.. (2025). Global prevalence and sex differences in rheumatic heart disease: a systematic review and updated meta-analysis. Frontiers in Cardiovascular Medicine. 12. 1615158–1615158.
2.
Jha, Prabhash Kumar, et al.. (2025). Vascular inflammation in chronic kidney disease: the role of uremic toxins in macrophage activation. Frontiers in Cardiovascular Medicine. 12. 1574489–1574489. 2 indexed citations
3.
Lupieri, Adrien, Prabhash Kumar Jha, Victor Nizet, et al.. (2025). Rheumatic heart valve disease: navigating the challenges of an overlooked autoimmune disorder. Frontiers in Cardiovascular Medicine. 12. 1537104–1537104. 1 indexed citations
4.
Lupieri, Adrien, Nicole Malet, Audrey Swiader, et al.. (2023). PI3KCIIα-Dependent Autophagy Program Protects From Endothelial Dysfunction and Atherosclerosis in Response to Low Shear Stress in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 44(3). 620–634. 5 indexed citations
6.
Jha, Prabhash Kumar, et al.. (2023). Computational Methods for Functional Characterization of lncRNAS inHuman Diseases: A Focus on Co-Expression Networks. Current Bioinformatics. 19(1). 21–38. 5 indexed citations
7.
Jha, Prabhash Kumar, Mark C. Blaser, Adrien Lupieri, et al.. (2022). Prothymosin Alpha: A Novel Contributor to Estradiol Receptor Alpha–Mediated CD8 + T-Cell Pathogenic Responses and Recognition of Type 1 Collagen in Rheumatic Heart Valve Disease. Circulation. 145(7). 531–548. 23 indexed citations
8.
Ganesh, Shanthi, et al.. (2021). Role of Vitronectin-Rich Protein Corona on Tumor-Specific siRNA Delivery and Transfection with Lipid Nanoparticles. Nanomedicine. 16(7). 535–551. 18 indexed citations
9.
Lupieri, Adrien, Yasufumi Nagata, Lívia Silva Araújo Passos, et al.. (2021). Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients. Frontiers in Cardiovascular Medicine. 8. 5 indexed citations
10.
Lupieri, Adrien, Régis Blaise, Alessandra Ghigo, et al.. (2020). A non-catalytic function of PI3Kγ drives smooth muscle cell proliferation after arterial damage. Journal of Cell Science. 133(13). 12 indexed citations
11.
Passos, Lívia Silva Araújo, et al.. (2020). Innate and adaptive immunity in cardiovascular calcification. Atherosclerosis. 306. 59–67. 50 indexed citations
12.
Smirnova, Natalia, Mélissa Buscato, Émeline Lhuillier, et al.. (2020). Tamoxifen Accelerates Endothelial Healing by Targeting ERα in Smooth Muscle Cells. Circulation Research. 127(12). 1473–1487. 21 indexed citations
13.
Lupieri, Adrien, et al.. (2020). Harnessing Single-Cell RNA Sequencing to Better Understand How Diseased Cells Behave the Way They Do in Cardiovascular Disease. Arteriosclerosis Thrombosis and Vascular Biology. 41(2). 585–600. 29 indexed citations
14.
Lupieri, Adrien, Natalia Smirnova, Romain Solinhac, et al.. (2019). Smooth muscle cells-derived CXCL10 prevents endothelial healing through PI3Kγ-dependent T cells response. Cardiovascular Research. 116(2). 438–449. 32 indexed citations
15.
Lupieri, Adrien, Natalia Smirnova, Nicole Malet, Stéphanie Gayral, & Muriel Laffargue. (2015). PI3K signaling in arterial diseases: Non redundant functions of the PI3K isoforms. Advances in Biological Regulation. 59. 4–18. 18 indexed citations
16.
Smirnova, Natalia, Coralie Fontaine, Mélissa Buscato, et al.. (2015). The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells. Circulation Research. 117(9). 770–778. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026